Getting The Disease Signature The Key For GSS

Yet another example of world-class Australian-developed biotechnology that is having an impact on the global market is Genetic Signatures Limited (GSS). The company’s 3base molecular scanning technology platform offers a quicker and more effective method for detecting entire classes of microbial species, allowing it to screen for a wide range of pathogens and diseases. The technology can potentially address a very large global market for molecular diagnostics (MDx) of human disease.

Read More